Tenet Healthcare Corp (THC) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
Tenet Healthcare's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period
Return on Investment, Quarterly Results, Trends, Rankings, Statistics
What is Tenet Healthcare's ROI in the second quarter of 2026? Tenet Healthcare Corp achieved a return on average invested assets (ROI) of 10.05 % in its second quarter of 2026, this is above THC's average return on investment of 1.95%. Tenet Healthcare Corps investments during the 12 months ending in the second quarter of 2026 are valued at $31 billion
ROI has improved compared to 9.38% in the first quarter of 2026, due to net income growth.
Within the Healthcare sector 106 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 761 to 914.
Tenet Healthcare Appoints Vineeta Agarwala, M.D., PhD, to its Board of Directors Tenet Healthcare Corporation (NYSE: THC) has recently announced the appointment of Vineeta Agarwala, M.D., PhD, to its Board of Directors, effective immediately. Dr. Agarwala brings a wealth of knowledge and experience to the position and will serve as a member of the Quality, Compliance, and Ethics Committee, as well as the Human Resources Committee. With this appointment, the size of the Tenet Board has increased to 13 directors. Saum Sutaria, M.D., Chairman, and Chief Executive Officer of Tenet, expressed his enthusiasm for Dr. Agarwala joining the Board. We are pleased to welcome Dr. Vineeta Agarwala to the Tenet Board, said Dr. Sutaria. Her expertise and insights will be invaluable as we continue to navigate the rapidly evolving healthcare landscape and drive our strategic growth initiatives.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
